Pfizer wins favorable Canadian ruling on Lipitor patent

03/23/2008 | American City Business Journals

Pfizer announced that the Federal Court of Appeal of Canada has upheld a patent that prevents generic-drug maker Ranbaxy Laboratories Ltd. from marketing a copy of Lipitor before the patent lapses in July 2010. A Pfizer representative said the ruling helps motivate drugmakers "to make the significant high-risk investments necessary to develop new life-saving medicines." Ranbaxy may ask the Supreme Court of Canada to review the decision.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health